概括
这项研究研究了甲状腺癌 (TC) 抑制疗法的风险,特别是在低风险患者中. 它还审查了对差异化TC治疗的指导方针的遵守.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 甲状腺癌 (TC) 是一种罕见但不断增长的癌症,主要影响女性.
- TC是异质的,包括差异化 (DTC),髓性 (MTC) 和亚塑性 (ATC) 类型.
- 差异化甲状腺癌 (DTC) 包括乳头细胞 (PTC),毛囊细胞 (FTC) 和赫特尔细胞 (HCC) 亚型.
研究的目的:
- 在差异化甲状腺癌 (DTC) 患者中分析抑制治疗的潜在不良影响.
- 专门调查与抑制疗法相关的心血管,骨和精神健康风险.
- 评估在DTC管理中遵守抑制治疗的既定指导方针.
主要方法:
- 文献综述侧重于差异化甲状腺癌的抑制疗法.
- 分析有关遵守临床指南的数据.
- 检查抑制治疗报告的副作用.
主要成果:
- 对DTC的抑制疗法具有潜在的风险,包括心血管,骨和精神健康问题.
- 这些风险对低风险的DTC患者尤为重要.
- 在DTC中遵守抑制疗法的指导方针有所不同.
结论:
- 仔细考虑抑制治疗风险至关重要,特别是在低风险的DTC患者中.
- 优化抑制疗法需要平衡益处与潜在的不良影响.
- 提高对指导方针的遵守程度可以提高DTC治疗的安全性和有效性.
相关概念视频
Drug Therapy
49
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
49
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
173
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
173
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Synthesis and Regulation of Thyroid Hormones
4.7K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539


